|
|
Other links at Articles > Pharmacists |
| 2. |
First-Time Generic Approvals: Procardia XL, Estrostep FE, Estrostep
|
|
|
The FDA has approved first-time generic formulations for nifedipine extended-release tablets in 90-mg strength; norethindrone acetate and ethinyl estradiol tablets (28-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths; and norethindrone acetate and ethinyl estradiol tablets (21-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths. Medscape Medical News
|
| 3. |
Etanercept Appears Effective, Well Tolerated for Giant Cell Arteritis
|
|
|
Etanercept may potentially replace corticosteroid therapy for patients with giant cell arteritis (GCA) who are experiencing adverse effects from the corticosteroid, according to the first randomized, double-blind, placebo-controlled trial of etanercept in patients with GCA. Reuters Health Information
|
| 4. |
Anakinra Plus a DMARD Improves Function in Rheumatoid Arthritis
|
|
|
The addition of anakinra to treatment with a traditional disease-modifying antirheumatic drug (DMARD) safely improves functional status in patients with active rheumatoid arthritis, according to research conducted in Europe. Reuters Health Information
|
| 5. |
Adding Tipifarnib After Imatinib Failure in CML Restores Antitumor Efficacy
|
|
|
When imatinib therapy has failed in patients with chronic myelogenous leukemia (CML) in chronic phase, adding the farnesyl transferase inhibitor tipifarnib restores activity against the disease and the combination is relatively well-tolerated, researchers report in the November 1st issue of Cancer. Reuters Health Information
|
|
|
